HHealth care Read More Eli Lilly (LLY) earnings Q1 2026April 30, 2026 David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the…
BBusiness Read More FDA testing speedier drug development with real-time clinical trialsApril 29, 2026 WASHINGTON — The Food and Drug Administration on Tuesday announced efforts to make clinical trials more efficient, starting…
SScience Read More Utah Startup Claims Its Lab-Grown Sperm Can Produce Embryos, in Potential Fertility BreakthroughApril 24, 2026 More than one in eight American men between the ages of 25 and 49 experience some form of…
BBusiness Read More UnitedHealth Group (UNH) earnings Q1 2026April 21, 2026 UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans |…
BBusiness Read More Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous rideApril 20, 2026 Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
HHealth Read More We’re freezing our eggs; maybe you should tooApril 14, 2026 Egg freezing is much more effective than most people think. Articles in major publications like The New York…
AArtificial intelligence Read More Novo Nordisk partners with OpenAI as AI drug discovery hopes mount April 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
HHealth care Read More Gilead to buy cancer biotech Tubulis for more than $3BApril 13, 2026 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
HHealth care Read More Terns, Merck, Gilead, Tubulis: Readout NewsletterApril 9, 2026 Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
HHealth Read More Study finds missed opportunities for targeted cancer treatmentsApril 8, 2026 Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…